First Workshop on Bioanalysis and Clinical Diagnosis, with an Emphasis on Lyme Disease

The first workshop of the EFA2/99 Nanolyme project, funded by the European Interreg Poctefa program, can be followed next Wednesday, April 1, at the Río Ebro Campus and on YouTube.. To be able to attend for free, you must complete a form

On Wednesday April 2, 09:30 a.m. to 12:30 p.m. will be able to attend The Workshops on bioanalysis and clinical diagnosis, with emphasis on Lyme, from EFA99/1 Nanolyme project: "Towards a new diagnosis of Lyme disease through nanotechnology, atomic spectrometry, and artificial intelligence" (Get more info).

The participation is totally free and open to the public (individuals, companies, institutions, organizations, etc.), with the only requirement being to register in order to have access to statistics on participation. For assist to the workshop funded by the European Interreg Poctefa programme It can be done in person at the i3a Seminar (Campus Río Ebro (R&D+i Building, C/Mariano Esquillor s/n 50018, Zaragoza) and by streaming. In both cases it is required to complete this form to confirm attendance, indicating the planet through which the day will continue.

Link to register for free: https://docs.google.com/forms/d/e/1FAIpQLSctXyImfEiYrA_m-pimVb3QLjlCkKLptdufkxHEOxhe0uOFBQ/viewform

Link to follow the workshop on YouTube: https://bit.ly/NlymeLive

Program of the 'I Workshop on Bioanalysis and Clinical Diagnosis, with an Emphasis on Lyme'

09:30 p.m. – Workshop presentation

• Dr. Martín Resano, University of Zaragoza (Spain)
• Dr. Christophe Pécheyran, IPREM CNRS (Pau, France)

09:35 h. - "Toward a new diagnosis of Lyme disease"

• Dr. Christophe Pécheyran, IPREM CNRS (Pau, France)

09:45 p.m. – "Treatment and diagnosis of Lyme disease"

• Dr. Raouf Ghozzi, Lannemezan Hospital (France)

10:15 p.m. – Development of monoclonal antibodies for the characterization of Borrelia

• Melanie Ramseyer, Diaclone SAS (France)

10:45 p.m. – "Nanostructured hybrid materials for biomedical applications"

• Dr. Joachim Allouche, IPREM CNRS (Pau, France)

11:15 p.m. – "Nanoparticle characterization and single-cell analysis using single-event ICP-MS"

• Antonio Bazo, University of Zaragoza (Spain)

11:45 p.m. – Café

12:30 p.m. – End of the workshop

Nanolyme Project

The project nanoLyme It is a cutting-edge initiative in medical research, whose main objective is Improve the diagnosis of Lyme disease, a bacterial infection transmitted by ticks carriers of the bacteria Borrelia/Lyme disease. This disease affects thousands of people each year in Europe and North America, but the main challenge facing health professionals is the early diagnosis, since the initial symptoms can be confused with those of other diseases. If not detected in time, the disease can cause serious long-term complications., affecting various parts of the body, such as the joints, nervous system and other organs.

NanoLyme seeks revolutionize disease diagnosis through the use of innovative technologies that allow the presence of the bacteria to be detected quickly and accurately, without depending on the patient's immune response. The project is based on the use of Nanotecnology, single cell mass spectrometry (single-cell ICP-MS) and Artificial Intelligence, tools that will provide a Greater sensitivity and accuracy in testing, even before symptoms are evident.

NanoLyme aims to overcome existing challenges in diagnosing Lyme disease, in particular, the limitation of current tests that detect infection once the immune system has begun to react. By using nanoparticles and advanced molecular analysis methods, this project seeks to identify the presence of the Borrelia/Lyme disease in minimal quantities, which would allow a early diagnostic.

One of nanoLyme's technological innovations is the development of a nanotechnology platform applied to diagnosisBy integrating nanotechnology and atomic spectrometry, researchers will be able to analyze biological samples at the cellular level, detecting the bacteria directly.

La mass spectrometry is a method that allows measuring the characteristics of particles and molecules at an atomic scale, which guarantees high precision in the identification of pathogens. In addition, the project incorporates artificial intelligence to analyze large volumes of data, optimizing test results and improving the efficiency of the diagnostic process.

In short, nanoLyme is developed around four key aspects:

• A more precise diagnosis: Development of a technique based on nanotechnology that allows the direct detection of the bacteria responsible for the disease.
• AI Application: Using artificial intelligence to process large amounts of data and improve diagnostic accuracy.
• Cross-border collaboration: Cooperation between institutions in the affected regions to develop a method applicable on a large scale.
• Better life quality: Reduce advanced cases of Lyme and improve patients' quality of life with earlier diagnosis.

With an eye to the future, nanoLyme seeks to lay the groundwork bases for new applications in the field of infectious diseases. It is hoped that the results of nanoLyme will serve as inspiration for other similar projects and that the developed technology is applied in other clinical contextsThe project is ready for

Read more about the project in the IIS Aragón website.

Source: University Institute of Engineering Research of Aragon, University of Zaragoza

Image: Representation of the Borrelia bacteria that causes Lyme disease / Nanolyme